Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach Key Takeaways The alopecia areata treatment landscape has transformed dramatically, moving beyond ineffective steroid-only approaches to targeted immune therapies that offer real hope for patients with severe hair loss. Three FDA-approved JAK inhibitors are
Tag: baricitinib
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies
The New Frontier in Longevity Science: Senolytics and Age-Reversal Therapies Introduction Approximately 80% of adults over age 65 worldwide develop at least one chronic condition, from arthritis to dementia. Recent longevity research has identified cellular senescence as a fundamental driver of age-related decline. These
